Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS) [NA]
Completed trial evaluating an online multimedia program to improve coping and function in prostate cancer survivors; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [Phase 1]
Phase 1 clinical trial update for NY-ESO-1 plasmid DNA cancer vaccine pPJV7611 in multiple cancers with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer [Phase 2]
A Phase 2 open-label randomized trial comparing monthly Ozarelix to Goserelin Depot in men with prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Postoperative Pain Control for Prostatectomy [NA]
A completed clinical trial evaluating postoperative pain control after prostatectomy related to prostate cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring sirolimus combined with docetaxel and carboplatin in metastatic castration-resistant prostate cancer; the study st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer [Phase 2]
Phase 2 trial update evaluating 68Ga-PSMA-11 PET/CT for influencing treatment decisions in biochemically recurrent and metastatic prostate c…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Effect of Epidural Anesthesia and Analgesia on Quality of Recovery After Radical Prostatectomy. [Phase 4]
Phase 4 clinical trial evaluating how epidural anesthesia and analgesia influence quality of recovery after radical prostatectomy.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer [Phase 2]
Phase 2 trial update of a selective androgen receptor modulator for symptom management in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer [Phase 2]
Phase 2 clinical trial update for RV001V in biochemical failure after curative therapy for localized prostate cancer.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: MRI-guided Focal Laser Ablation [Phase 2]
Phase 2 trial update for MRI-guided focal laser ablation in prostate cancer is listed but status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy [Phase 2]
Phase 2 clinical trial update evaluating metabolic changes in prostate cancer bone metastases using 68Ga-HBED-CC-PSMA PET/CT after Radium-22…
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine [NA]
A completed pilot study evaluating immunogenicity of candidate PSA peptides for a prostate cancer vaccine; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 trial update of talazoparib in men with DNA repair defects and metastatic castration-resistant prostate cancer has completed with re…
-
FDA approval · 2021-09-07FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for ERLEADA (apalutamide) from Janssen Products, LP, indicating an expanded authorization for the dr…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy [Phase 2]
Completed Phase 2 study evaluating neoadjuvant and adjuvant abiraterone acetate plus apalutamide in men with prostate cancer undergoing pros…
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® [Phase 3]
Phase 3 trial evaluating LY01005 versus ZOLADEX in prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial) [Phase 2]
Phase 2 clinical trial investigating nivolumab in prostate cancer with DNA repair defects (ImmunoProst trial) is ongoing with unknown status…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating Gallium-68 PSMA-11 PET imaging in prostate cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer [Phase 2]
Phase 2 neoadjuvant trial of enoblituzumab (MGA271) in men with localized intermediate- and high-risk prostate cancer; results were posted i…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: 177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC [Phase 1, Phase 2]
A combination trial of 177Lu-J591 and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer was conducted in Phase 1/2 and subse…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) [Phase 2]
Phase 2 clinical trial update evaluating cabazitaxel in metastatic castration-resistant prostate cancer patients with AR-V7 positive circula…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 [Phase 3]
Phase 3 clinical trial comparing early rising PSA endocrine treatment versus chemo-endocrine therapy (SPCG14) for prostatic neoplasms.
-
FDA approval · 2021-08-13FDA Approved: LEUPROLIDE ACETATE — Original Application (NorthStar RxLLC)
FDA approved the Leuprolide acetate original application (ANDA213829) for a generic version, issued to NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer [Phase 2, Phase 3]
A completed Phase 2/3 study evaluating 18F-DCFPyL PET/CT imaging in prostate cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Perioperative Post-Prostatectomy Incontinence Home Telehealth Program [NA]
Completed clinical trial evaluating a perioperative post-prostatectomy incontinence home telehealth program; results posted in 2021.